YAP1 and non-small cell lung carcinoma: found through further studies revealed that silencing of CCT3 resulted in the inhibition of Yes-associated protein 1 (YAP1) in NSCLC cells, decreasing the expression of YAP1 target genes and producing antitumor effects in NSCLC.